← All trials
NCT01294670
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2011
- Primary completion
- Feb 1, 2018
- Completion date
- Feb 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 27
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Cornell UniversityLead sponsor
- MerckCollaborator
- Cornell UniversityOverall official - principal investigator
- Johns Hopkins UniversityCollaborator
- University of ArizonaCollaborator
- University of FloridaCollaborator
- University of Texas at HoustonCollaborator
- University of CalgaryCollaborator
- Arnold Palmer Hospital for ChildrenCollaborator
- Harvard UniversityCollaborator
- University of ColoradoCollaborator
- Pennsylvania State UniversityCollaborator
- University of KansasCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.